Lon­nie Moul­der’s new biotech play grabs $118M, steer­ing in­to PhI­II and more deals

3 months ago
Deals

Ex­clu­sive: Mt. Ever­est al­most got in the way of a tR­NA biotech, but hC Bio­science climbs to Se­ries A ex­ten­sion

3 months ago
Financing
Startups

Scoop: Call­ing off an IPO, a can­cer and Covid-19 vac­cine mak­er rais­es a Se­ries C

3 months ago
Financing
Startups

JP Mor­gan splash­es in­to the life sci­ences, tap­ping Stephen Squin­to to run ven­ture team with high-pow­ered ad­vi­sors

3 months ago
Deals
Bioregnum

Covid-19 spurred a his­toric vac­cine R&D ef­fort. What does it mean for fu­ture pan­demics?

3 months ago
R&D
Coronavirus

A biotech paused a gene ther­a­py hatched by fam­i­lies. Now they want con­trol

3 months ago
Cell/Gene Tx
In Focus

Ex­clu­sive: Strug­gling Ed­i­tas shops pre­clin­i­cal can­cer pipeline dur­ing its big makeover

3 months ago
Deals

Dis­ease aware­ness daze: Do pa­tients and peo­ple tune out health con­di­tion months and re­lat­ed mar­ket­ing?

3 months ago
Pharma
Marketing

Af­ter call­ing a lengthy time out on the de­vel­op­ment field, Al­lo­gene fi­nal­ly kicks off a land­mark PhII piv­otal

4 months ago
R&D

Q&A: No­vo Nordisk dig­i­tal in­no­va­tion chief Amy West dis­cuss­es phar­ma pain points and a health­care 'easy but­ton’

4 months ago
Pharma
Marketing

Sanofi turns to a Jen­nifer Doud­na gene edit­ing up­start for next-gen NK cell al­liance

4 months ago
Deals

Even as pan­dem­ic re­cedes, short-staffed tri­al sites leave can­cer pa­tients wait­ing

4 months ago
R&D
Pharma

The End­points 11: Fire­side chat with No­bel Prize lau­re­ate Phil Sharp

4 months ago

An­ti­bod­ies once act­ed on­ly as pro­tein block­ers. Now, sci­en­tists are find­ing new ways to make them pro­tein de­stroy­ers

4 months ago
Discovery

The End­points 11: The top pri­vate biotechs in pur­suit of new drugs. Push­ing the en­ve­lope with pow­er­ful new tech­nolo­gies

4 months ago
Special

Lab coats and mi­cro­scopes in mar­ket­ing: Does sci­ence still sell in phar­ma ad­ver­tis­ing?

4 months ago
Pharma
Marketing

#ES­MO22: Round­table dis­cus­sion with John Car­roll

4 months ago

Backed by five phar­ma gi­ants and a crew of Penn su­per­stars, a start­up us­es mR­NA to cre­ate in vi­vo CAR-T — with a pro at the helm

4 months ago
Financing
Startups

#ES­MO22: Am­gen drops the de­tailed deck for KRAS G12C, with erod­ing da­ta like­ly to trig­ger fresh de­bate

4 months ago
R&D

#ES­MO22: 'End of the be­gin­ning': As PD-(L)1s press on, how far can com­bo ther­a­pies take im­muno-on­col­o­gy?

4 months ago
R&D
Pharma

#ES­MO22: Am­gen spot­lights con­fir­ma­to­ry win for KRAS G12C play­er Lumakras in lung can­cer — but there's plen­ty more da­ta to come

5 months ago
R&D

Noth­ing to laugh about: What hap­pened to hu­mor in phar­ma ad­ver­tis­ing?

5 months ago
Pharma
Marketing

Phar­ma's day in court: Is the dai­ly down­pour of law­suits giv­ing phar­ma com­pa­nies a bad rep?

5 months ago
Pharma
Marketing

Chi­na's DNA gi­ant con­fronts skep­ti­cism in US ex­pan­sion bid

5 months ago
China
In Focus
First page Previous page 1234567 Next page Last page